3 Medtech Earnings Winners
In this week's episode of Industry Focus: Healthcare, host Shannon Jones talks with Motley Fool medtech guru Brian Feroldi about three earnings reports from three fantastic medtech companies: Guardant (NASDAQ: GH), the leader in liquid biopsies, and the game-changing diabetes players Dexcom (NASDAQ: DXCM) and Insulet (NASDAQ: PODD). Tune in to find out what each of these companies does and why it's so good for patients and business, how they performed this quarter, some of the biggest risks and competitive threats to look out for, what kind of growth runways they have ahead of them, which one looks like the most appealing buy for long-term investors today, and much more.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com
